top of page
Jonathan Poyer

M&A Continues - Eli Lilly Ponies Up $1.4B for Point Biopharma




Week Ending September 29th, 2023

  • Biotech: 8 Transactions (4 Follow-Ons, 2 PIPEs, and 2 RDs) totaling just under $2 Billion

  • Med Tech: No Current Week Transactions


2023 YTD

  • 134 Biotech transactions totaling just under $20 Billion v. 2022: 113 Biotech transactions totaling just under $14 Billion

  • 15 Med Tech transactions totaling just over $1 Billion v. 2022: 10 Med Tech transactions just under $900 Million


Private Transactions:

  • Biotech: 182 Transactions / 53 European Transactions

  • Med Tech: 100 US Transactions / 33 European Transactions


October Major Transactions:


  • AbbVie acquired Mitokinin - $110M

  • Kyowa Kirin acquired Orchard Therapeutics - $387M; $16/Share

  • Eli Lilly acquired Point Biopharma - $1.4B; $12.50/Share

September Major Transactions:


  • Alfasigma acquired Intercept Pharmaceuticals - $794M; $19/Share


August Major Transactions:


  • Otsuka Pharmaceutical acquired Mindset Pharma - $59M; $0.75/Share

  • Harmony Biosciences acquired Zynerba Pharmaceuticals - $60M; $1.11/Share

  • Regeneron acquired Decibel Therapeutics - $107M; $4/Share



16 views0 comments

Comentarios


bottom of page